FRANKFURT (Reuters) - German drugmaker Merck KGaA's cancer vaccine Stimuvax has failed to meet its goal of improving the survival of lung cancer patients in a late-stage trial. "It is disappointing that the... trial did not meet its prima...
Source: http://health.yahoo.net/news/s/nm/merck-kgaa-cancer-drug-stimuvax-fails-late-stage-trial
Christina Katherine Jackson Chad Ochocinco Glen Rice
No comments:
Post a Comment
Note: only a member of this blog may post a comment.